2026-10-04 · 2026-10 / week-1
No-trade screen: Reject. Pyxis Oncology closed an offering that raised about $110 million gross, not $282.6 million. The remaining $172.6 million depends on up to 49.3 million warrants becoming exercisable after a charte...
2026-10-04 · 2026-10 / week-1
Summary: Qorvo's last regular-session close, $114.17 on Oct. 2, was already essentially equal to the $114.1288 consideration implied by Skyworks' $32.50 cash plus 0.960 SWKS shares, marked to SWKS's $85.03 close. Skywork...
2026-10-04 · 2026-10 / week-1
No-trade screen: Reject. Edwards’ owned Autus subsidiary won FDA approval for a size-adjustable pediatric pulmonary valve, a real new treatment option, but neither the FDA nor Edwards disclosed a commercial launch date, ...
2026-10-03 · 2026-10 / week-1
No-trade screen: Reject. On Oct. 2, BNB Plus said it would move from a BNB-treasury strategy toward blockchain and AI infrastructure and explore ways to monetize its LineaRx subsidiary. No asset sale, customer contract, ...
2026-10-03 · 2026-10 / week-1
No-trade screen: Reject. A report says FHFA may direct Fannie Mae and Freddie Mac to accept two-bureau rather than three-bureau mortgage reports. That would matter to Equifax, but the report is not an issued policy, and ...
2026-10-03 · 2026-10 / week-1
No-trade screen: Reject. CareTrust closed the first 24-home tranche of its UK deal and raised FY2026 normalized FFO guidance, but the remaining 21 homes depend on construction and regulatory approvals through 2027, while...
2026-10-03 · 2026-10 / week-1
No-trade screen: Reject. Integra’s Oct. 2 preliminary update cut full-year reported revenue guidance by about 1.8% and adjusted EPS guidance by 4.1%. A separate, proposed $600 million secured loan is intended to refinanc...
2026-10-02 · 2026-10 / week-1
No-trade screen: Reject. September payrolls came in well below the cited Reuters consensus, prior months were revised down, and wage growth slowed. A regular-session snapshot at 9:46:12 a.m. EDT showed TLT at $78.06, up ...
2026-10-02 · 2026-10 / week-1
No-trade screen: Reject. Medtronic’s split-off is not an 80% dilution event: MiniMed will redeem Medtronic-held shares and issue an equal number to participating holders, so total shares stay broadly unchanged while owne...
2026-10-02 · 2026-10 / week-1
Summary: onsemi and Synaptics signed an amended merger agreement on Oct. 1 that replaces the June all-stock exchange with $123 cash per SYNA share. A timestamped Oct. 2 premarket observation was already $121.50, leaving ...
2026-10-02 · 2026-10 / week-1
No-trade screen: Reject. Veritone’s registered offering is expected to add 20 million shares at $0.75, but its latest filed balance sheet showed only $12.4 million of cash against $45.58 million of convertible notes due ...
2026-10-02 · 2026-10 / week-1
Summary: Synopsys disclosed a genuine, multiyear agreement with Amazon worth more than $1 billion, spanning custom-silicon IP, licensing and royalties, and engineering software. SNPS then closed Oct. 1 at $490.54, up 12....
2026-10-02 · 2026-10 / week-1
No-trade screen: Reject. The September U.S. Employment Situation is scheduled before the Oct. 2 open, and 20+ year Treasury yields have risen sharply. But at TLT’s Oct. 1 close, a roughly 69-basis-point parallel yield ri...
2026-10-02 · 2026-10 / week-1
Summary: Nike’s fiscal Q1 revenue fell 4% and missed the pre-print consensus cited by secondary providers, while EPS beat and gross margin expanded 60 basis points. Management still expects high-single-digit FY27 revenue...
2026-10-02 · 2026-10 / week-1
Summary: National Fuel completed its $2.62 billion Ohio utility acquisition on Oct. 1, adding about 335,000 customers and doubling its regulated utility rate base. Yet the deal’s $1.20 billion seller note matures in a ye...
2026-10-01 · 2026-10 / week-1
Summary: An 8:00 a.m. EDT GlobeNewswire issuer release, syndicated by StockTitan, says the Powerus-Aureus Greenway merger was completed effective Oct. 1; TheFly separately reports the announcement. Filed terms estimate f...
2026-10-01 · 2026-10 / week-1
Summary: Acuity reported Q4 FY26 adjusted EPS of $5.77, up 11%, on net sales growth of 2.9%. But the $44.9 million Q4 tariff refund helped reported earnings, Acuity Brands Lighting ABL adjusted operating profit fell 7.1%...
2026-10-01 · 2026-10 / week-1
Summary: Accenture’s Q4 FY26 revenue was $18.68 billion, above its prior guide, and bookings grew 5% in local currency. But the new FY27 outlook is only 3%–6% local-currency revenue growth and 3%–6% adjusted-EPS growth; ...
2026-10-01 · 2026-10 / week-1
Summary: McCormick’s Q3 sales growth was mostly acquired, and Consumer volume/mix fell 1.1%, while the company reaffirmed its FY26 guide. But adjusted operating income rose 22%, adjusted EPS edged higher, and the pending...
2026-10-01 · 2026-10 / week-1
Summary: Micron’s FY26 Q4 revenue of $54.23 billion exceeded its prior guide, non-GAAP gross margin reached 87.0%, and Q1 FY27 guidance rises to $61.5 billion of revenue. The fresh cash/claim bridge is less simple: $12.7...